Hyam Levitsky, EVP, Research & CSO at Juno Therapeutics, Inc. (JUNO), sold 24,536 shares at $42.76 ($1.0M) on 2016-06-17, disclosed to the SEC on 2016-06-21.
Open-market sale of $1.0M JUNO by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.76 | 12,118 | $518K | 49.4% |
| 2 | $42.76 | 12,118 | $518K | 49.4% |
| 3 | $43.20 | 300 | $13K | 1.2% |
| Total | $42.77 avg | 24,536 | $1.0M | 100% |